Assessment of the in vitro growing dynamics and kinetics of the non-pathogenic J and pathogenic 11 and 232 Mycoplasma hyopneumoniae strains
- PMID: 29801517
- PMCID: PMC5970506
- DOI: 10.1186/s13567-018-0541-y
Assessment of the in vitro growing dynamics and kinetics of the non-pathogenic J and pathogenic 11 and 232 Mycoplasma hyopneumoniae strains
Abstract
Information on the in vitro growth of pathogenic and non-pathogenic Mycoplasma hyopneumoniae (M. hyopneumoniae) strains is scarce and controversial. Despite its limitations, the colour changing units (CCU) assay is still considered the golden standard titration technique for M. hyopneumoniae culture. Thus, the aims of the present study were: (1) to describe the growth dynamics and kinetics of pathogenic and non-pathogenic M. hyopneumoniae strains, and (2) to monitor the strains' daily growth by ATP luminometry, CCU, colony forming units (CFU), and DNA quantification by real time quantitative PCR (qPCR) and by fluorescent double-stranded DNA (dsDNA) staining, to evaluate them as putative titration methodologies. The growth of the non-pathogenic J (ATCC®25934™) type strain and the pathogenic 11 (ATCC®25095™) reference strain and 232 strain was modelled by the Gompertz model. Globally, all three-strain cultures showed the same growing phases as well as similar maximal titres within a particular technique, but for CFU. However, the J strain displayed the fastest growing. During the logarithmic phase of growing, CCU, ATP and M. hyopneumoniae copy titres were strongly and linearly associated, and correlation between techniques could be reliably established. In conclusion, real-time culture titration by means of ATP or molecular assays was useful to describe the in vitro growth of the tested strains. Knowledge about the in vitro growth behaviour of a specific strain in a specific medium may provide several advantages, including information about the time required to reach maximal titres by the culture. Noteworthy, the obtained results refers to the three strains used, so extrapolation to other M. hyopneumoniae strains or culture conditions should be made cautiously.
Figures







Similar articles
-
Validation of ATP luminometry for rapid and accurate titration of Mycoplasma hyopneumoniae in Friis medium and a comparison with the color changing units assay.J Microbiol Methods. 2010 Dec;83(3):335-40. doi: 10.1016/j.mimet.2010.09.001. Epub 2010 Sep 17. J Microbiol Methods. 2010. PMID: 20851152
-
Development of a quantitative SYBR Green real-time PCR and microscopic slide culture for in vitro enumeration of Mycoplasma hyopneumoniae.Lett Appl Microbiol. 2025 Feb 3;78(2):ovaf011. doi: 10.1093/lambio/ovaf011. Lett Appl Microbiol. 2025. PMID: 39932826
-
Evaluation of virulence of Mycoplasma hyopneumoniae field isolates.Vet Microbiol. 2003 Dec 30;97(3-4):177-90. doi: 10.1016/j.vetmic.2003.08.008. Vet Microbiol. 2003. PMID: 14654289
-
Pathogenicity & virulence of Mycoplasma hyopneumoniae.Virulence. 2020 Dec;11(1):1600-1622. doi: 10.1080/21505594.2020.1842659. Virulence. 2020. PMID: 33289597 Free PMC article. Review.
-
Mycoplasma hyopneumoniae variability: Current trends and proposed terminology for genomic classification.Transbound Emerg Dis. 2019 Sep;66(5):1840-1854. doi: 10.1111/tbed.13233. Epub 2019 Jun 4. Transbound Emerg Dis. 2019. PMID: 31099490 Review.
Cited by
-
Genotyping and biofilm formation of Mycoplasma hyopneumoniae and their association with virulence.Vet Res. 2022 Nov 17;53(1):95. doi: 10.1186/s13567-022-01109-x. Vet Res. 2022. PMID: 36397177 Free PMC article.
-
Paracellular Pathway-Mediated Mycoplasma hyopneumoniae Migration across Porcine Airway Epithelial Barrier under Air-Liquid Interface Conditions.Infect Immun. 2020 Sep 18;88(10):e00470-20. doi: 10.1128/IAI.00470-20. Print 2020 Sep 18. Infect Immun. 2020. PMID: 32747599 Free PMC article.
-
Methylsulfonylmethane ameliorates inflammation via NF-κB and ERK/JNK-MAPK signaling pathway in chicken trachea and HD11 cells during Mycoplasma gallisepticum infection.Poult Sci. 2022 Apr;101(4):101706. doi: 10.1016/j.psj.2022.101706. Epub 2022 Jan 10. Poult Sci. 2022. PMID: 35121233 Free PMC article.
-
Screening of immunogenic proteins and evaluation of vaccine candidates against Mycoplasma synoviae.NPJ Vaccines. 2023 Aug 15;8(1):121. doi: 10.1038/s41541-023-00721-y. NPJ Vaccines. 2023. PMID: 37582795 Free PMC article.
-
Performance of Commercial Mycoplasma hyopneumoniae Serum Enzyme-Linked Immunosorbent Assays under Experimental and Field Conditions.J Clin Microbiol. 2020 Nov 18;58(12):e00485-20. doi: 10.1128/JCM.00485-20. Print 2020 Nov 18. J Clin Microbiol. 2020. PMID: 32967897 Free PMC article.
References
-
- Rose DL, Tully JG, Wittler RG. Taxonomy of some swine Mycoplasmas: Mycoplasma suipneumoniae Goodwin et al. 1965, a later, objective synonym of Mycoplasma hyopneumoniae Maré and Switzer 1965, and the Status of Mycoplasma flocculare Meyling and Friis 1972. Int J Syst Evol Microbiol. 1979;29:83–91.
-
- Thacker EL, Minion FC. Mycoplasmosis. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of swine. Iowa: Wiley-Blackwell; 2012.
-
- Zielinski GC, Ross RF. Effect of growth in cell cultures and strain on virulence of Mycoplasma hyopneumoniae for swine. Am J Vet Res. 1990;51:344–348. - PubMed
-
- Bereiter M, Young TF, Joo HS, Ross RF. Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. Vet Microbiol. 1990;25:177–192. doi: 10.1016/0378-1135(90)90075-7. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources